Vectorite Biomedical Stock

Vectorite Biomedical EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Vectorite Biomedical (4170.TWO) as of Aug 4, 2026 is -27.87. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -23.51 — a change of 18.55% (lower).

EV/EBIT

-27.87

YoY

18.55%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Vectorite Biomedical is 2026 -27.87 . EV/EBIT (Enterprise Value to EBIT) of Vectorite Biomedical was 2025 -23.51 . It decreases by 18.55% lower compared to the previous year.

The Vectorite Biomedical EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2018
-13.83 base
Jan 1, 2019
-6.28 base
Jan 1, 2020
-5.54 base
Jan 1, 2021
-9.95 base
Jan 1, 2022
16.56 base
Jan 1, 2023
-57.79 base
Jan 1, 2024
-24.01 base
Jan 1, 2025
-27.97 base
YEARPRICE-TO-EBIT
2025 -27.97
2024 -24.01
2023 -57.79
2022 16.56
2021 -9.95
2020 -5.54
2019 -6.28
2018 -13.83
2017 -33.94
2016 -10.92
2015 -18.26
2014 -48.87
2013 -15.54
2012 -
2011 -
2010 -
Access this data via the Eulerpool API
Get Free API Key

Vectorite Biomedical Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Vectorite Biomedical's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Vectorite Biomedical's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Vectorite Biomedical's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Vectorite Biomedical grows earnings faster than its peers.

Vectorite Biomedical Stock analysis

What does Vectorite Biomedical do? Vectorite Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vectorite Biomedical stock

EV/EBIT (Enterprise Value to EBIT) of Vectorite Biomedical is -27.87 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Vectorite Biomedical changed from -23.51 to -27.87, representing a 18.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Vectorite Biomedical since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Vectorite Biomedical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Vectorite Biomedical

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Vectorite Biomedical